<![CDATA[Predicting Severe Immune-Related Toxicities in Lung Cancer Immunotherapy]]>
Owen explained that no single test can yet predict which patients will develop serious toxicities from immune checkpoint inhibitors. He noted that a history of autoimmune disease is a known risk factor, but patients with no identifiable risk factors can …